Al Ittihad Drug Store
Al Ittihad Drug Store (IDS) is a UAE-based B2B pharmaceutical and consumer healthcare distributor serving government hospitals, private hospitals, and retail pharmacies, with 99% UAE coverage and 40+ global principals. IDS is a wholly-owned Mubadala Bio subsidiary operating under the Pharma Logistics vertical.
- Company typePrivate
- Founded1987
- HeadquartersDubai, United Arab Emirates
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Al Ittihad Drug Store does
Al Ittihad Drug Store (IDS) is a Dubai-headquartered, B2B pharmaceutical and consumer healthcare distributor serving the United Arab Emirates. Founded in 1987, the company operates a comprehensive distribution network reaching 99% of UAE pharmacies and 100% of government and private hospitals, executing 70,000+ deliveries per year within a 12-24 hour on-time window. It distributes products for 40+ global pharmaceutical and consumer health partners, including Bayer, Novartis, Sanofi, GlaxoSmithKline, Sandoz, Aurobindo, Acino, Alfasigma, and Merz, providing these principals with end-to-end market access support in the UAE.
IDS organizes its offering into six service modules: Regulatory Affairs & Pharmacovigilance (approvals, compliance, market access), Advanced Pharma Logistics (supply chain operations), Sales & Marketing (commercial execution), Institutional & Market Access (penetration of government and private accounts), Digital & Operational Excellence (process and digital optimization), and Distribution & Supply Chain (last-mile delivery). The platform combines regulatory expertise, distribution scale, and commercial execution to act as the UAE entry and growth vehicle for global healthcare principals.
Al Ittihad Drug Store is a wholly-owned subsidiary of Mubadala Bio, the life-sciences arm of Mubadala Investment Company, having transitioned from 80% Mubadala ownership in December 2024 to full ownership in February 2026, alongside the related Global Medical Supply Chain (GMSC) entity under the Pharma Logistics vertical. Its revenue model combines transaction-based pharmaceutical distribution with professional-services revenue from regulatory affairs, pharmacovigilance, and market access engagements; pricing is quote-based and not publicly disclosed. The customer base spans three primary segments — government hospitals, private hospitals, and retail pharmacies — with global healthcare companies functioning as both principals and channel partners.
Al Ittihad Drug Store firmographics
Firmographics- Name
- Al Ittihad Drug Store
- Legal name
- Al Ittihad Drug Store
- Website
- https://ids.ae
- Company type
- Private
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Al Ittihad Drug Store (IDS) is a UAE-based B2B pharmaceutical and consumer healthcare distributor serving government hospitals, private hospitals, and retail pharmacies, with 99% UAE coverage and 40+ global principals. IDS is a wholly-owned Mubadala Bio subsidiary operating under the Pharma Logistics vertical.
- Ownership category
- akta.pro rank
Where Al Ittihad Drug Store is headquartered
LocationHeadquarters
- HQ city
- Dubai
- HQ country
- United Arab Emirates
- HQ region
- Middle East
Offices1 record
Markets served
Al Ittihad Drug Store business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Infrastructure, Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Pharmaceutical Distribution: Revenue generated from distributing pharmaceutical and consumer healthcare products to government and private hospitals and pharmacies across the UAE
- Market Access Services: Commercial execution and market access support services for global healthcare companies entering the UAE market
- Regulatory Services: Regulatory affairs and pharmacovigilance support services
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Al Ittihad Drug Store product offering
Product offeringCore offering
Al Ittihad Drug Store (IDS) is a UAE-based B2B distributor and market access partner for pharmaceutical and consumer healthcare products. It provides end-to-end distribution to government hospitals, private hospitals, and 99% of pharmacies in the UAE, supported by regulatory affairs, pharmacovigilance, sales and marketing execution, and advanced pharma logistics capabilities.
Product overview
Al Ittihad Drug Store (IDS) operates as a unified healthcare distribution platform under Mubadala Bio's Pharma Logistics vertical, offering an integrated suite of six interconnected service modules. The platform combines Regulatory Affairs & Pharmacovigilance for compliance navigation, Advanced Pharma Logistics for supply chain operations, Sales & Marketing for commercial execution, Institutional & Market Access for market penetration, Digital & Operational Excellence for efficiency optimization, and Distribution & Supply Chain for last-mile delivery. Founded in 1987 and now part of Mubadala Bio following full acquisition in 2026, IDS serves as a healthcare distribution and market access partner supporting the full lifecycle of pharmaceutical and consumer healthcare products in the UAE market.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical Distribution & Supply Chain
Quantifiable outcome
- 70,000+ deliveries annually
- +4 more outcomes
Companies that use Al Ittihad Drug Store
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles4 records
Al Ittihad Drug Store technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Al Ittihad Drug Store partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and minor.
- L-NutracoreIDS signed an exclusive distribution agreement with L-Nutra to expand access to longevity-focused nutrition solutions in the UAE. This partnership strengthens IDS's portfolio in the consumer healthcare segment.
- GlobalOne Healthcare Holding (GHH)minorPrevious parent company from which Mubadala acquired the 80% stake in December 2024. GHH retained 20% stake following initial acquisition.
- BayercorePharmaceutical partner displayed in IDS partner logos section
- NovartiscorePharmaceutical partner displayed in IDS partner logos section
- SanoficorePharmaceutical partner displayed in IDS partner logos section
- GlaxoSmithKline (GSK)corePharmaceutical partner displayed in IDS partner logos section
- SandozcorePharmaceutical partner displayed in IDS partner logos section
- Global Medical Supply Chain (GMSC)coreAffiliated company under Mubadala Bio; acquired alongside IDS as part of Mubadala's healthcare logistics vertical integration strategy
- AurobindominorPharmaceutical partner displayed in IDS partner logos section
- AcinominorPharmaceutical partner displayed in IDS partner logos section
- AlfasigmaminorPharmaceutical partner displayed in IDS partner logos section
- MerzminorPharmaceutical partner displayed in IDS partner logos section
Scale indicators5 records
Recent moves4 records
Expansion highlights4 records
Al Ittihad Drug Store competitors and assessment
Company assessmentDirect peers
- Global Medical Supply Chain (GMSC): GMSC is the sister company of IDS under Mubadala Bio's Pharma Logistics vertical, also acquired in 2024–2026. It operates in adjacent healthcare logistics and distribution in the UAE, making it the most directly comparable peer.
Regional players
- Julphar (Gulf Pharmaceutical Industries): Julphar is one of the largest pharmaceutical manufacturers based in the UAE with regional GCC distribution reach. While primarily a manufacturer, it competes for shelf space and institutional contracts that IDS distributes, making it a relevant regional comparable.
- SPIMACO Addwaa: SPIMACO is a leading Saudi pharmaceutical manufacturer and distributor serving the GCC. Its regional distribution footprint across Saudi Arabia and adjacent markets makes it a geographic peer, though it is Saudi-domiciled rather than UAE.
- Tabuk Pharmaceuticals: Tabuk is a major Saudi-based pharmaceutical manufacturer with growing GCC presence. It is comparable as a regional pharma player whose products flow through similar hospital and pharmacy channels in the GCC.
- Dallah Healthcare Holding: Dallah Healthcare is a Saudi healthcare conglomerate operating hospitals, clinics and pharmaceutical distribution. It serves a comparable role as a regional, integrated healthcare distribution and services platform — though primarily in Saudi Arabia.
Broad incumbents
- Hikma Pharmaceuticals: Hikma is a multinational pharmaceutical company with significant MENA manufacturing and distribution operations. As a broader incumbent in regional pharma supply, it competes for similar institutional customers and represents the larger-scale player IDS benchmarks against.
- Aster DM Healthcare: Aster DM Healthcare operates a large network of pharmacies, clinics and hospitals across the GCC and India. Its pharmacy retail and pharmaceutical distribution operations in the UAE overlap directly with IDS's downstream pharmacy channels.
- McKesson Corporation: McKesson is one of the world's largest pharmaceutical wholesalers and distributors. While operating at vastly different scale and geography, it represents the global best-practice benchmark for the distribution model IDS executes in the UAE.
- Cencora (formerly AmerisourceBergen): Cencora is a global pharmaceutical distribution and solutions company serving manufacturers and healthcare providers. As a broad incumbent in pharma distribution, it defines the global operational and commercial benchmarks for companies like IDS.
Emerging players
- BinSina Pharmacy: BinSina is a UAE pharmacy retail chain that is a downstream customer of pharmaceutical distributors like IDS. It is comparable as an emerging player in UAE pharmacy distribution and retail, sitting on the buy-side of IDS's value chain.
Market position
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Al Ittihad Drug Store social profiles
Digital presenceAl Ittihad Drug Store compliance and trust
Trust signalCompliance3 records
Al Ittihad Drug Store financial estimates
Financial estimateRevenue estimate
Valuation estimate
Al Ittihad Drug Store leadership team
Management profileNumber of profiles
Al Ittihad Drug Store funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Al Ittihad Drug Store M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Al Ittihad Drug Store
What does Al Ittihad Drug Store do?
Al Ittihad Drug Store (IDS) is a UAE-based B2B distributor and market access partner for pharmaceutical and consumer healthcare products. It provides end-to-end distribution to government hospitals, private hospitals, and 99% of pharmacies in the UAE, supported by regulatory affairs, pharmacovigilance, sales and marketing execution, and advanced pharma logistics capabilities.
Is Al Ittihad Drug Store a public or private company?
Al Ittihad Drug Store is a private company. It is classified as corporate owned and is currently operating.
When was Al Ittihad Drug Store founded?
Al Ittihad Drug Store was founded in 1987. It employs 251 to 500 people.
Where is Al Ittihad Drug Store based?
Al Ittihad Drug Store is headquartered in Dubai, United Arab Emirates, in the Middle East region.
How does Al Ittihad Drug Store make money?
Three revenue lines are on record. Pharmaceutical Distribution is the primary driver. The others are market Access Services and regulatory Services.
Who are Al Ittihad Drug Store's main competitors?
Global Medical Supply Chain (GMSC) is listed as a direct peer. Regional players are Julphar (Gulf Pharmaceutical Industries), SPIMACO Addwaa, Tabuk Pharmaceuticals and Dallah Healthcare Holding. Broad incumbents are Hikma Pharmaceuticals, Aster DM Healthcare, McKesson Corporation and Cencora (formerly AmerisourceBergen). BinSina Pharmacy is listed as an emerging player.
Does Al Ittihad Drug Store have an API?
No public API is recorded for Al Ittihad Drug Store.